Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Jan 1 2022


  • Snapshot
  • Introduction
    • One of 7 medications used for asthma aimed to reduce inflammation and obstruction
      • corticosteroids
      • β-agonists
      • muscarinic agonists
      • methylxanthines
      • cromolyn
      • antileukotrienes
      • omalizumab
  • Omalizumab
    • Mechanism of action
      • monoclonal antibody against IgE
        • binds and inhibits free serum IgE
      • IgE is involved in bronchoconstriction and recruitment of inflammatory cells to combat allergens
        • therefore, omalizumab lessens these responses
    • Clinical uses
      • moderate-to-severe persistent asthma
        • symptoms must be inadequately controlled on inhaled corticosteroids
        • must have IgE-mediated allergy to at least 1 year-round allergen, proven by allergen skin test
        • must have elevated serum IgE levels
      • chronic idiopathic urticaria
    • Adverse effects
      • hypersensitivity reactions
        • local injection site reactions
        • urticaria
        • anaphylaxis
          • 1-2 out of 1000
      • serum sickness-like reaction
        • very rare, only case reports
        • treatment
          • discontinue omalizumab and give antihistamines
          • glucocorticoids for severe symptoms
1 of 0
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options